ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,655Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 761

$527K Total Retail Price of All Prescriptions

Rank: 111 out of 761

560 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 10,064 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 594 541 1 1
SIMVASTATIN 505 485 2 2
HYDROCODONE-ACETAMINOPHEN 415 344 S3 3 5
LEVOTHYROXINE SODIUM 403 318 4 3
AMLODIPINE BESYLATE 338 301 5 6
LOSARTAN POTASSIUM 294 260 6 13
METFORMIN HCL 292 245 7 10
ATORVASTATIN CALCIUM 242 237 8 12
FUROSEMIDE 233 221 9 7
METOPROLOL TARTRATE 231 230 10 14
ATENOLOL 221 192 11 8
OMEPRAZOLE 219 141 12 4
CITALOPRAM HBR 214 201 13 19
HYDROCHLOROTHIAZIDE 207 197 14 11
LOVASTATIN 181 138 15 17
METOPROLOL SUCCINATE 167 158 16 16
WARFARIN SODIUM 167 167 16 9
POTASSIUM CHLORIDE 159 155 18 18
ZOLPIDEM TARTRATE 141 115 19 22
FLUOXETINE HCL 110 100 20 31
TAMSULOSIN HCL 100 100 21 27
ALLOPURINOL 98 91 22 28
TRAZODONE HCL 96 77 23 23
DOXAZOSIN MESYLATE 93 86 24 55
SERTRALINE HCL 92 79 25 25
ALENDRONATE SODIUM 91 91 26 21
RAMIPRIL 89 89 27 127
OXYCODONE-ACETAMINOPHEN 88 50 S2 28 49
DONEPEZIL HCL 82 82 29 33
MIRTAZAPINE 79 75 30 50
PANTOPRAZOLE SODIUM 77 72 31 40
SPIRIVA 76 69 32 56
BISOPROLOL-HYDROCHLOROTHIAZIDE 74 68 33 193
ROPINIROLE HCL 72 68 34 95
FLUTICASONE PROPIONATE 71 59 35 29
GLIPIZIDE 70 67 36 39
ADVAIR DISKUS 68 66 37 37
POLYETHYLENE GLYCOL 3350 68 45 37 62
CARVEDILOL 68 51 37 26
PAROXETINE HCL 67 56 40 47
TRIAMTERENE-HYDROCHLOROTHIAZID 66 66 41 68
GLYBURIDE 63 51 R 42 77
TRIAMTERENE-HCTZ 63 54 42 42
SYNTHROID 62 62 44 64
DIOVAN 60 60 45 58
AZITHROMYCIN 59 53 46 70
PROAIR HFA 58 50 47 32
GABAPENTIN 57 39 48 15
LOSARTAN-HYDROCHLOROTHIAZIDE 55 55 49 65
CYCLOBENZAPRINE HCL 53 35 R 50 51
CLONIDINE HCL 53 53 50 69
MORPHINE SULFATE ER 52 33 S2 52 38
NABUMETONE 52 48 52 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.